- Home
- LUNG vs OCCIN Comparison
LUNG vs OCCIN Comparison
Compare LUNG & OCCIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- OCCIN
- Stock Information
- Founded
- LUNG 1995
- OCCIN N/A
- Country
- LUNG United States
- OCCIN United States
- Employees
- LUNG N/A
- OCCIN N/A
- Industry
- LUNG Industrial Specialties
- OCCIN Trusts Except Educational Religious and Charitable
- Sector
- LUNG Health Care
- OCCIN Finance
- Exchange
- LUNG Nasdaq
- OCCIN Nasdaq
- Market Cap
- LUNG N/A
- OCCIN N/A
- IPO Year
- LUNG 2020
- OCCIN N/A
- Fundamental
- Price
- LUNG $3.40
- OCCIN $24.03
- Analyst Decision
- LUNG Strong Buy
- OCCIN
- Analyst Count
- LUNG 7
- OCCIN 0
- Target Price
- LUNG $11.59
- OCCIN N/A
- AVG Volume (30 Days)
- LUNG 388.2K
- OCCIN N/A
- Earning Date
- LUNG 04-30-2025
- OCCIN N/A
- Dividend Yield
- LUNG N/A
- OCCIN N/A
- EPS Growth
- LUNG N/A
- OCCIN N/A
- EPS
- LUNG N/A
- OCCIN N/A
- Revenue
- LUNG $87,473,000.00
- OCCIN N/A
- Revenue This Year
- LUNG $18.02
- OCCIN N/A
- Revenue Next Year
- LUNG $18.17
- OCCIN N/A
- P/E Ratio
- LUNG N/A
- OCCIN N/A
- Revenue Growth
- LUNG 19.84
- OCCIN N/A
- 52 Week Low
- LUNG $2.83
- OCCIN N/A
- 52 Week High
- LUNG $9.37
- OCCIN N/A
- Technical
- Relative Strength Index (RSI)
- LUNG 40.16
- OCCIN 50.31
- Support Level
- LUNG $2.83
- OCCIN $23.99
- Resistance Level
- LUNG $3.25
- OCCIN $24.28
- Average True Range (ATR)
- LUNG 0.27
- OCCIN 0.07
- MACD
- LUNG 0.09
- OCCIN -0.01
- Stochastic Oscillator
- LUNG 61.29
- OCCIN 24.82
About OCCIN OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation primarily through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.